← back to search

Jiao Ma

Tongji University · CN
Area of research
Pathology and Forensic Medicine · Electrical and Electronic Engineering
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Perovskite Materials and Applications, Chronic Lymphocytic Leukemia Research, and Acute Myeloid Leukemia Research.
h-index
22
citations
1,940
works
69
NIH funding
primary concept
email

Recent publications

Irisin attenuates acute lung injury by suppressing the pyroptosis of alveolar macrophages
International Journal of Molecular Medicine 2023cited by 27position: middledoi
Irisin Ameliorates PM2.5-Induced Acute Lung Injury by Regulation of Autophagy Through AMPK/mTOR Pathway
Journal of Inflammation Research 2023cited by 20position: firstdoi
Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development
Nature Communications 2021cited by 136position: middledoi
Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in <i>IGH-BCL2</i> + diffuse large B-cell lymphomas
Blood 2021cited by 42position: lastdoi
Senp2 regulates adipose lipid storage by de-SUMOylation of Setdb1
Journal of Molecular Cell Biology 2017cited by 55position: middledoi
Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma
Oncotarget 2015cited by 55position: firstdoi
Ibrutinib Resistance in Chronic Lymphocytic Leukemia
New England Journal of Medicine 2014cited by 299position: middledoi
Functional characterization of BTKC481S mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors
Leukemia 2014cited by 155position: middledoi
Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells
British Journal of Haematology 2014cited by 89position: firstdoi
Treatment advances of non-cystic fibrosis bronchiectasis
Chinese Journal of Asthma 2014cited by 0position: firstdoi
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity
Leukemia 2013cited by 184position: middledoi
BTK Inhibition Targets in Vivo CLL Proliferation Through Its Effects On B-Cell Receptor Signaling Activity.
Blood 2012cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ailin Guo · University of Exeter6 papers (2012–2015)Y. Lynn Wang · North Sichuan Medical University6 papers (2012–2015)Morton Coleman · Cornell University5 papers (2012–2014)Shuhua Cheng · Changchun University of Technology5 papers (2012–2021)Richard R. Furman · Cornell University3 papers (2012–2014)Pin Lu · Fox Chase Cancer Center3 papers (2012–2014)Rui Jiao · Hebei Medical University2 papers (2023–2023)John P. Leonard · NYU Langone Health2 papers (2012–2013)Jinke Cheng · Tongren Hospital2 papers (2017–2021)Aihong Meng · Hebei Medical University2 papers (2023–2023)Joseph J. Buggy · Collaborative Drug Discovery (United States)2 papers (2012–2013)Zhuoxiao Han · First Hospital of Qinhuangdao2 papers (2023–2023) · 2 papers (2017–2021)Guanli Yuan · First Hospital of Qinhuangdao2 papers (2023–2023)Tianshi Wang · Huaiyin Normal University1 papers (2017–2017) · 1 papers (2021–2021)Karen Dresser · University of Massachusetts Chan Medical School1 papers (2015–2015)Jingqi Zhou · Fudan University1 papers (2021–2021)Xixin Yan · Hebei Medical University1 papers (2023–2023)Wenhan Wang · Shandong University1 papers (2021–2021)